Profile

First Time US Pharmaceuticals (India) Pvt. Ltd. (FTUP) is a USFDA registered and audited facility and a subsidiary of USpharma Ltd., established in 2013 under the leadership of Dr. Manesh Dixit, a professional and an entrepreneur.

Our Mission

To be a global leader in pharmaceutical industry by providing innovative products of assured quality at an affordable price.

Our Vision

To utilise available talents and technologies for the development of niche products that stands differently from the current treatment regimen. To serve the customer with needed formulation and analytical support.

Who we are

First Time US Pharmaceuticals (India) Pvt. Ltd. is a one stop solution for all pharma needs that may include analytical services to the industry, formulation development of various dosage forms covering BCS class I to class IV drugs using in-house and novel platform technologies. FTUP has already developed products in the field of transdermal and topical, metered and non-metered spray technologies, soft chew tablets and semi solids for veterinary and human use. All these products are unique and have its own technological advantages and has potential for patent ability. Few patents are already at place. The company has special knowledge for solubility/bio-availability improvement of insoluble drugs, controlled and targeted release for improved compliance and developing bio-equivalent products as part of generic product development requirement. FTUP has been successful in stabilizing difficult to stabilize products and is ready to take up projects with potent and narrow therapeutic index drugs and difficult to achieve bio-equivalence products. FTUP can undertake technology transfer of already developed products and is well versed with current approaches and regulatory needs such as QbD, PAT and process qualification needs. FTUP regulatory team is well versed with submission requirements and other requirements such as CBE 30, PAS and other regulatory documentation needs. FTUP has successfully co-developed 9 ANDAs with our US counterpart. Our site is USFDA registered and audited facility approved.

Quality Policy

Developing and providing pharmaceutical products and services of assured quality with outstanding level of commitment to integrity, reliability, delivery and continuous improvement at competitive price in compliance with the relevant laws and regulations.

Management Team

Dr. Manesh Dixit

ceo

View Details

Dr. Parthasarthy Sen

President

View Details

Mr. Vibhor Misar

Director

View Details